Παρασκευή 1 Νοεμβρίου 2019

Clonal hematopoiesis in human aging and disease
As people age, their tissues accumulate an increasing number of somatic mutations. Although most of these mutations are of little or no functional consequence, a mutation may arise that confers a fitness advantage on a cell. When this process happens in the hematopoietic system, a substantial proportion of circulating blood cells may derive from a single mutated stem cell. This outgrowth, called "clonal hematopoiesis," is highly prevalent in the elderly population. Here we discuss recent advances...
MedWorm Cancer & Oncology News
Thu Oct 31, 2019 00:00
Aromatase inhibitors and risk of cardiovascular events in breast cancer patients: a systematic review and meta-analysis.
CONCLUSIONS: These results suggest that patients with breast cancer treated with AIs do not have a significant risk of developing CVEs in comparison with the controls, and exemestane might not be considered as the alternative AI to the breast cancer patients from the perspective of CVEs. Further studies are recommended to investigate this association and the risk differences among different tumor types, AIs or treatment regimens. PMID: 31665091 [PubMed - in process] (Source: BMC Pharmacology...
MedWorm Cancer & Oncology Research
06:40
Emerging role of ubiquitin-specific protease 14 in oncogenesis and development of tumor: Therapeutic implication
Publication date: Available online 30 October 2019Source: Life SciencesAuthor(s): Bing Liu, Jiangping Chen, Song ZhangAbstractUbiquitin (Ub) is a small protein that can be attached to substrate proteins to direct their degradation via the proteasome. Deubiquitinating enzymes (DUBs) reverse this process by removing ubiquitin from its substrate protein. Over the past few decades, ubiquitin-specific protease 14 (USP14), a member of the DUBs, has emerged as an important player in various types of cancers....
MedWorm Cancer & Oncology Research
06:39
Aldehyde dehydrogenase-2 acts as a potential genetic target for renal fibrosis
Publication date: Available online 31 October 2019Source: Life SciencesAuthor(s): Simin Tang, Teng Huang, Huan Jing, Zhenxing Huang, Hongtao Chen, Youling Fan, Jiying Zhong, Jun ZhouAbstractObstructive renal injury and drug-induced nephrotoxicity are the two most common causes of renal fibrosis diseases. However, whether these two different pathogeny induced same pathological outcomes contain common genetic targets or signaling pathway, the current research has not paid great attention. GSE121190...
MedWorm Cancer & Oncology Research
06:39
Experimental data and thermodynamic modeling of solubility of Sorafenib tosylate, as an anti-cancer drug, in supercritical carbon dioxide: Evaluation of Wong-Sandler mixing rule
This article is the first to examine an anti-cancer medicine, namely Sorafenib tosylate, in terms of its solubility in SC-CO2. This was done in different ranges of pressure (120-270 bar) and temperature (308-338 K). For this purpose, solubility data correlation was performed via two main sets of techniques; these included (1) two equations of states (EoSs), namely Peng-Robinson (PR) and Soave–Redlich–Kwong (SRK) with vdW2 and Wong-Sandler mixing rules (with two activity models: NRTL and Wilson) and...
MedWorm Cancer & Oncology Research
06:13
Galactose-modified enzymatic synthesis of poly(amino-co-ester) micelles for co-delivery miR122 and sorafenib to inhibit hepatocellular carcinoma development
In this study, we aim to develop efficient materials as vectors for co-delivery of microRNA-122 (miR-122) and sorafenib (SRF). We successfully synthesized amphiphilic galactose-modified PEGylated poly(amino-co-ester) (Gal-PEG-PPMS) copolymers consisted of hydrophilic Gal-PEG5k chain segments and hydrophobic poly(ω-pentadecalactone-co-N-methyldiethyleneamine-co-sebacic acid) chain segments, which self-assembled to form cationic micelles at pH 5.2. The results showed that the micelles could encapsulate...
MedWorm Cancer & Oncology Research
06:12
Cumulative effects of cadmium and natural stressors (temperature and parasite infection) on molecular and biochemical responses of juvenile rainbow trout
This study aimed to evaluate the combined effects of chronic exposure to cadmium (Cd) and elevated water temperature (23 °C) or parasite infection in juvenile rainbow trout (Oncorhynchus mykiss) using a multi-level biological approach, including RNA-sequencing. Fish were exposed to diet-borne Cd (6 μg Cd/g wet feed), individually and in combination with thermal (23 °C) or parasitic stressors, for 28 days. The parasite challenge consisted of a single exposure to glochidia (larvae) of the freshwater...
MedWorm Cancer & Oncology Research
06:05
Green synthesized zinc oxide nanoparticles regulates the apoptotic expression in bone cancer cells MG-63 cells
Publication date: Available online 30 October 2019Source: Journal of Photochemistry and Photobiology B: BiologyAuthor(s): Jun Cheng, Xiaofeng Wang, Le Qiu, Yunkai Li, Najat Marraiki, Abdallah M. Elgorban, Li XueAbstractManagement of degenerative spine pathologies frequently leads to the need for bone growth. Rehmanniae Radix (RR), a Chinese herbal formulation was found to exhibit numerous therapeutic properties including its potent effect against cancer cell lines. However, the underlying mechanism...
MedWorm Cancer & Oncology Research
05:14
The HLA-G 14 bp allele frequency in different populations: A global meta-analysis
Publication date: Available online 30 October 2019Source: Meta GeneAuthor(s): Jessyca Kalynne Farias Rodrigues, Sergio Crovella, Ronaldo Celerino da SilvaAbstractHLA-G gene encodes a non-classical molecule of major histocompatibility complex with important immunomodulatory properties, being expressed, primarily by cytotrophoblasts during pregnancy, or in pathological conditions (autoimmune diseases, cancer, transplants and viral infections). The insertion of 14 bp in HLA-G 3′UTR region has been related...
MedWorm Cancer & Oncology Research
05:09
Molecular subtypes of colorectal cancer: an emerging therapeutic opportunity for personalized medicine
Publication date: Available online 30 October 2019Source: Genes & DiseasesAuthor(s): Manish Pratap Singh, Sandhya Rai, Ashutosh Pandey, Nand K. Singh, Sameer SrivastavaAbstractMolecular subtypes-based therapies offer new potential framework for desired and precise outcome in clinical settings. Current treatment strategies in colorectal cancer is largely ‘one drug fit all’ model for patients that display same pathological conditions. However, CRC is a very heterogenous set of malignancy that does...
MedWorm Cancer & Oncology Research
05:09
How Do We Respond to Men with BRCA Mutations when They Ask About Prostate Cancer?
Publication date: Available online 30 October 2019Source: European UrologyAuthor(s): Fatima Karzai, Ravi A. Madan, William L. Dahut (Source: European Urology)
MedWorm Cancer & Oncology Research
04:41
Re: Brian I. Rini, Thomas Powles, Michael B. Atkins, et al. Atezolizumab plus Bevacizumab Versus Sunitinib in Patients with Previously Untreated Metastatic Renal Cell Carcinoma (IMmotion151): A Multicentre, Open-label, Phase 3, Randomised Controlled Trial. Lancet 2019;393:2404–15: Putting IMmotion into Motion: Personalizing Frontline Treatment for Metastatic Renal Cell Carcinoma
Publication date: Available online 30 October 2019Source: European UrologyAuthor(s): Nirmish Singla (Source: European Urology)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Research
04:41
An Up-to-date predictive model for rectal cancer survivorship reflecting tumor biology and clinical Factors
ConclusionThe current model incorporates histopathological and clinical factors. It emphasizes the importance of tumor biological factors like tumor deposits in predicting overall and disease-free survival in rectal cancer.SummaryRectal cancer outcomes are associated with certain clinical and pathological factors that can be evaluated. Tumor deposits are one such factor that can affect overall and disease-free survival. (Source: The American Journal of Surgery)
MedWorm Cancer & Oncology Research
04:11
Comparison of signal detection of tumour necrosis factor- α inhibitors using the Korea Adverse Events Reporting System Database, 2005–2016
ConclusionsSeven new signals that were not included in the current label were identified for TNF α inhibitors and should be updated and monitored.Key Points•Large-scale spontaneous AE reporting data and data mining techniques are useful for detecting signals of rare AEs as well as common AEs induced by drugs.•Drug labels should be updated to reflect signals that are newly discovered by continuous monitoring. (Source: Clinical Rheumatology)
MedWorm Cancer & Oncology Research
00:00
Modeling Complexity: The Case of Cancer-Related Venous Thromboembolism.
Authors: Khorana AA PMID: 31665801 [PubMed - in process] (Source: Thrombosis and Haemostasis)
MedWorm Cancer & Oncology Research
00:00
Attitudes Of Chinese Cancer Patients Toward The Clinical Use Of Artificial Intelligence
(Source: Patient Preference and Adherence)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 23:31

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου